--- title: "Pre-market hot trades in US stocks: Cuprina up 104.61% pre-market; Mawson Infrastructure up 25.79% pre-market" type: "News" locale: "en" url: "https://longbridge.com/en/news/281847580.md" description: "Cuprina pre-market up 104.61%; Mawson Infrastructure pre-market up 25.79%; Advanced Biomed pre-market up 69.46%; Huachen AI Parking Management Tech pre-market up 59.10%; Silo Pharma pre-market up 48.93%" datetime: "2026-04-07T08:02:34.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281847580.md) - [en](https://longbridge.com/en/news/281847580.md) - [zh-HK](https://longbridge.com/zh-HK/news/281847580.md) --- # Pre-market hot trades in US stocks: Cuprina up 104.61% pre-market; Mawson Infrastructure up 25.79% pre-market **Pre-market Hot Trades in US Stocks** Cuprina, up 104.61% in pre-market trading, has no significant news recently. The trading is active with clear capital flow, and considering the sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Mawson Infrastructure is up 25.79% in pre-market trading. Based on recent key news: 1. On April 6, Mawson Infrastructure announced a partnership agreement with Endeavor and appointed five new board members. This move aims to enhance corporate governance and transparency by introducing the expertise and diverse perspectives of new members, driving company growth. This news boosted the stock price. 2. On April 6, Ryan Costello of Mawson Infrastructure resigned as chairman of the board. This change is seen as part of a restructuring of the company's governance, and the market reacted positively, leading to an increase in the stock price. 3. On April 6, Mawson Infrastructure released a governance update, emphasizing its competitiveness in environmentally friendly and carbon-conscious digital infrastructure solutions. This strategic positioning has enhanced investor confidence, further driving the stock price up. The market reacted positively to the governance restructuring, pushing the stock price higher. **Top Gainers in Pre-market US Stocks** Advanced Biomed is up 69.46% in pre-market trading. Based on recent key news: 1. On April 2, Advanced Biomed signed an agreement to acquire 100% of Acellent Technologies (Hong Kong). This move aims to expand its AI-driven financial verification and auditing solutions, expected to enhance its technological infrastructure and cross-industry positioning. The total transaction value is approximately $1.08 million, subject to financial and legal due diligence and obtaining necessary regulatory approvals. Source: SEC announcement. 2. On April 4, Advanced Biomed expanded its product portfolio through strategic acquisitions, showing interest in integrating advanced data and analytical capabilities, potentially broadening its technological and market coverage. Source: Simply Wall St. 3. On April 4, market sentiment towards Advanced Biomed's technology signaled a strong sell, yet despite its market capitalization of $6.21 million, the acquisition news significantly boosted the stock price. Source: Simply Wall St. The biopharmaceutical industry is expanding AI technology applications. Huachen AI Parking Management Tech is up 59.10% in pre-market trading, with no significant news recently. The trading is active with clear capital flow, and considering the sector and industry trends, the stock shows significant volatility, with specific reasons needing further observation. Silo Pharma is up 48.93% in pre-market trading. Based on recent key news: 1. On April 6, Silo Pharma announced that its patent application for the 5-HT4 pathway therapy was approved by the European Patent Office. This decision expands the company's intellectual property portfolio and enhances market confidence in its preventive treatment potential, driving the stock price up. 2. On April 7, Silo Pharma's stock price soared from $0.36 to over $0.50 in after-hours trading, showing a strong market response. According to Benzinga's Edge stock rankings, although Silo Pharma's price trend has been negative across all time frames, this short-term increase reflects the market's positive reaction to its patent news. 3. On April 7, in overnight trading, Silo Pharma's stock price reached $0.59, up 66.84%. This significant price fluctuation indicates investor optimism regarding the company's recent patent developments. The biotechnology industry has seen frequent patent activity recently, attracting high market attention ### Related Stocks - [CUPR.US](https://longbridge.com/en/quote/CUPR.US.md) - [MIGI.US](https://longbridge.com/en/quote/MIGI.US.md) - [BGDE.US](https://longbridge.com/en/quote/BGDE.US.md) ## Related News & Research - [How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here](https://longbridge.com/en/news/286786866.md) - [AI face is taking over — and driving plastic surgeons crazy](https://longbridge.com/en/news/286641783.md) - [Jack Antonoff tells people who are making AI art to 'drive right off that cliff'](https://longbridge.com/en/news/286592426.md) - [Neurovia AI CTO at ISNR: Solving the AI Data Cost Dilemma and Unleashing Infrastructure Capacity | AIIO Stock News](https://longbridge.com/en/news/287049307.md) - [Intelligent Protection Management Corp. Launches IPM Private Cloud AI Offering | IPM Stock News](https://longbridge.com/en/news/286896871.md)